Company: RGNX
Filing Date: 2025-11-26
Form Type: S-3
Source: 0001193125-25-300539
Chunk: 40

Company: REGENXBIO Inc.
Filing Date: 2025-11-26
Form: S-3
Chunk 40
---
 that we will indemnify each of our directors, executive officers
and such other key employees against any and all expenses incurred by that director, executive officer, or other key employee because of his or her status as one of our directors, executive officers, or other key employees, to the fullest extent
permitted by Delaware law, our restated certificate of incorporation and our amended and restated bylaws. In addition, the form agreement provides that, to the fullest extent permitted by Delaware law, we will advance all expenses incurred by our
directors, executive officers and other key employees in connection with a legal proceeding.

We currently carry and intend to continue to
carry liability insurance for our directors and officers.

At present, there is no pending litigation or proceeding involving any of our
directors, officers or employees in which indemnification will be required or permitted. We are not aware of any threatened litigation or proceeding that might result in a claim for such indemnification.

II-2

| Item 16. | Exhibits |

| Exhibit 
 Number  
 1.1*    
 4.1     
 4.2     |     | Description                                                                                                                                                            
 Form of Underwriting Agreement.                                                                                                                                        
 Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on January 7, 2021).          
 Amended and Restated Bylaws (incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on September 22, 2015).                 |
|:--------|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.3     |     | Description of Common Stock (incorporated herein by reference to Exhibit 4.2 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2024).        |
| 4.4     |     | Specimen stock certificate evidencing shares of the Company’s common stock, par value $0.0001 per share (incorporated herein by reference                              
 to Exhibit 4.1 to the Company’s Registration Statement on Form S-1 filed on August 17, 2015).                                                                          |
| 4.5*    |     | Form of Certificate of Designation with respect to any preferred stock issued hereunder and the related Form of Preferred Stock Certificate.                           |
| 4.6*    |     | Form of Warrant Agreement and W